Open the Podcasts app and search for The Doctor’s Farmacy. If you’re viewing this site on your phone, you can just tap on the

Tap the subscribe button and new shows will be added to your library.

If you’re using a different device, our show is available on the following platforms.

Listen On

Apple Podcast Subscribe See all Players New to Podcasts? View Transcripts View Transcripts

Episode 111

The Doctor's Farmacy

COVID-19: Where Are We Now And Where Do We Go From Here?

Open the Podcasts app and search for The Doctor’s Farmacy. If you’re viewing this site on your phone, you can just tap on the

Tap the subscribe button and new shows will be added to your library.

If you’re using a different device, our show is available on the following platforms.

View all Platforms

Listen On

Apple Podcast Subscribe See all Players New to Podcasts? View Transcripts View Transcripts

While we can’t be sure what’s in store for us with the future of COVID-19, we can try to learn from the past to tackle this situation in the smartest way possible.

That means looking at previous infectious disease epidemics and understanding zoonotic diseases like this one, that are passed from animals to humans, and how they’re different from the other pandemic diseases we’ve been able to eradicate.

I was excited to connect with Dr. Steven Gordon to dig into these topics deeper, today on The Doctor’s Farmacy.

Dr. Gordon is the person to talk to when it comes to gaining a better understanding of infectious diseases. He explains some of the unique characteristics of SARS-CoV-2 and how they will dictate the way we move forward with healthcare and as a society in the coming years. The good news is that Dr. Gordon has a positive outlook about our ability to cope with COVID-19.

Throughout our talk we break down some of the other most common phrases and questions associated with the pandemic. Dr. Gordon explains the concept of herd immunity in an easy-to-understand way and we discuss what we currently do and don’t know about antibodies and immunity.

When it comes to the numbers, we’re hearing daily changes on infection rates and mortality rates. Identifying more people that have been infected but were asymptomatic means a decrease in the mortality rate. Dr. Gordon provides some interesting insights into how this could change our perspective of COVID-19.

We also talk about the future of medicine after the pandemic, what vaccine studies are showing us, and so much more.

I hope you’ll tune in to feel as educated as possible during this time.

In this episode, you will learn:

Lessons learned from previous infectious disease epidemics

(3:08 / 3:11)
Unique characteristics of SARS-CoV-2 and how they will influence our ability to move forward as a society over the next few years

(6:09 / 6:12)
Evaluating infection rates, antibody testing, and mortality rates

(9:36 / 9:39)
Do we need widespread testing, and is it even possible?

(11:59 / 12:02)
Why are some locations affected more than others by coronavirus?

(13:50 / 13:53)
Treatments for COVID-19, what we’ve tried and what might be coming

(18:41 / 18:44)
Why a COVID-19 vaccine might not be the magic bullet we’ve been waiting for

(22:47 / 22:51)
Wearing masks and other culture change for effective COVID-19 prevention

(31:15 / 31:18)
Dr. Gordon’s coronavirus projections for the next two years

(35:30 / 35:33)
Can you get COVID-19 more than once?

(38:25 / 38:28)
How healthcare could improve if 5G and internet were a free utility for all

(46:24 / 46:27)

Guest

Mark Hyman, MD

Mark Hyman, MD is the Founder and Director of The UltraWellness Center, the Head of Strategy and Innovation of Cleveland Clinic's Center for Functional Medicine, and a 13-time New York Times Bestselling author.

If you are looking for personalized medical support, we highly recommend contacting Dr. Hyman’s UltraWellness Center in Lenox, Massachusetts today.

Learn More

Dr. Steven Gordon

Dr. Gordon is the Chairman of the Department of Infectious Diseases at the Cleveland Clinic Foundation and Professor of Medicine at the Lerner College of Medicine at Case Western University. His clinical interests include infective endocarditis including cardiac electronic implantable device infections as well as opportunistic infections in immunocompromised patients. He is a Fellow in the American College of Internal Medicine and a Member of the Infectious Disease Society of America.